ID   MF-R 3
AC   CVCL_D3XS
DR   Wikidata; Q127382803
RX   PubMed=38057796;
CC   Doubling time: 21 +- 2.1 hours (PubMed=38057796).
CC   Derived from site: In situ; Forearm, hypodermis; UBERON=UBERON_0002386+UBERON_0002072.
ST   Source(s): PubMed=38057796
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 11,12
ST   D18S51: 14,20
ST   D19S433: 14
ST   D21S11: 28
ST   D2S1338: 17,25
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 21,24
ST   Penta D: 10
ST   Penta E: 7,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
RX   PubMed=38057796; DOI=10.1186/s12885-023-11658-9; PMCID=PMC10698968;
RA   Guerrieri, Ania Naila
RA   Bellotti, Chiara
RA   Penzo, Marianna
RA   Columbaro, Marta
RA   Pannella, Micaela
RA   De Vita, Alessandro
RA   Gambarotti, Marco
RA   Mercatali, Laura
RA   Laranga, Roberta
RA   Dozza, Barbara
RA   Vanni, Silvia
RA   Corsini, Serena
RA   Frisoni, Tommaso
RA   Miserocchi, Giacomo
RA   Ibrahim, Toni
RA   Lucarelli, Enrico
RT   "A novel patient-derived immortalised cell line of myxofibrosarcoma: a
RT   tool for preclinical drugs testing and the generation of near-patient
RT   models.";
RL   BMC Cancer 23:1194.1-1194.13(2023).
//